{"entity":{"type":"insider","cik":"0001504783","url":"/insider/0001504783","json_url":"/insider/0001504783.json","name":"Lippoldt Darin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":91,"n_filings":63,"first":"2012-02-17","last":"2026-07-13","span_basis":"filed_date"},"name_variants":[{"name":"Lippoldt Darin","source":"filing","n_filings":63,"first_seen":"2012-02-17","last_seen":"2026-07-13"}],"transactions":[{"id":6186055,"accession":"0001504783-26-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001504783-26-000017","line_url":"/filing/0001504783-26-000017#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":179.6014,"price_display":"179.60","price_state":"stated","total_value":1796014.0,"total_display":"1,796,014.00","total_whole":"1,796,014","shares_owned_after":54729.0,"shares_owned_after_display":"54,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-13","scope":"insider"},{"id":5824131,"accession":"0001504783-26-000015","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001504783-26-000015","line_url":"/filing/0001504783-26-000015","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9800.0,"shares_display":"9,800","price_per_share":170.1611312244898,"price_display":"170.16","price_state":"stated","total_value":1667579.086,"total_display":"1,667,579.09","total_whole":"1,667,579","shares_owned_after":54729.0,"shares_owned_after_display":"54,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-06-30","scope":"insider","n_lines":2},{"id":5824124,"accession":"0001504783-26-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001504783-26-000015","line_url":"/filing/0001504783-26-000015#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":169.565,"price_display":"169.56","price_state":"stated","total_value":33913.0,"total_display":"33,913.00","total_whole":"33,913","shares_owned_after":54729.0,"shares_owned_after_display":"54,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":4893415,"accession":"0001504783-25-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001504783-25-000006","line_url":"/filing/0001504783-25-000006#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4376.0,"shares_display":"4,376","price_per_share":159.647,"price_display":"159.65","price_state":"stated","total_value":698615.272,"total_display":"698,615.27","total_whole":"698,615","shares_owned_after":43405.0,"shares_owned_after_display":"43,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":4129044,"accession":"0000914475-25-000065","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000914475-25-000065","line_url":"/filing/0000914475-25-000065","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2184.0,"shares_display":"2,184","price_per_share":116.75477884615384,"price_display":"116.75","price_state":"stated","total_value":254992.437,"total_display":"254,992.44","total_whole":"254,992","shares_owned_after":42474.0,"shares_owned_after_display":"42,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider","n_lines":2},{"id":4452809,"accession":"0000914475-25-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000050","line_url":"/filing/0000914475-25-000050#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":911.0,"shares_display":"911","price_per_share":118.2514,"price_display":"118.25","price_state":"stated","total_value":107727.0254,"total_display":"107,727.03","total_whole":"107,727","shares_owned_after":41679.0,"shares_owned_after_display":"41,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":5190282,"accession":"0000914475-25-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000026","line_url":"/filing/0000914475-25-000026#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":152.9064,"price_display":"152.91","price_state":"stated","total_value":191133.0,"total_display":"191,133.00","total_whole":"191,133","shares_owned_after":40863.0,"shares_owned_after_display":"40,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider"},{"id":3150165,"accession":"0000914475-24-000185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000185","line_url":"/filing/0000914475-24-000185#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2996.0,"shares_display":"2,996","price_per_share":154.013,"price_display":"154.01","price_state":"stated","total_value":461422.948,"total_display":"461,422.95","total_whole":"461,423","shares_owned_after":39740.0,"shares_owned_after_display":"39,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-05","scope":"insider"},{"id":3200073,"accession":"0000914475-24-000168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000168","line_url":"/filing/0000914475-24-000168#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7004.0,"shares_display":"7,004","price_per_share":149.9986,"price_display":"150.00","price_state":"stated","total_value":1050590.1944,"total_display":"1,050,590.19","total_whole":"1,050,590","shares_owned_after":39740.0,"shares_owned_after_display":"39,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-18","scope":"insider"},{"id":2170838,"accession":"0000914475-24-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000074","line_url":"/filing/0000914475-24-000074#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1098.0,"shares_display":"1,098","price_per_share":132.9949,"price_display":"132.99","price_state":"stated","total_value":146028.4002,"total_display":"146,028.40","total_whole":"146,028","shares_owned_after":39740.0,"shares_owned_after_display":"39,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":2300280,"accession":"0000914475-24-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000048","line_url":"/filing/0000914475-24-000048#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":911.0,"shares_display":"911","price_per_share":134.2359,"price_display":"134.24","price_state":"stated","total_value":122288.9049,"total_display":"122,288.90","total_whole":"122,289","shares_owned_after":38755.0,"shares_owned_after_display":"38,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-08","filed_date":"2024-02-08","scope":"insider"},{"id":2300273,"accession":"0000914475-24-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000048","line_url":"/filing/0000914475-24-000048#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1041.0,"shares_display":"1,041","price_per_share":142.1663,"price_display":"142.17","price_state":"stated","total_value":147995.1183,"total_display":"147,995.12","total_whole":"147,995","shares_owned_after":37939.0,"shares_owned_after_display":"37,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":2942244,"accession":"0000914475-24-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000029","line_url":"/filing/0000914475-24-000029#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":140.6478,"price_display":"140.65","price_state":"stated","total_value":175809.75,"total_display":"175,809.75","total_whole":"175,810","shares_owned_after":37005.0,"shares_owned_after_display":"37,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":3200032,"accession":"0000914475-24-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000011","line_url":"/filing/0000914475-24-000011#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":139.8553,"price_display":"139.86","price_state":"stated","total_value":1398553.0,"total_display":"1,398,553.00","total_whole":"1,398,553","shares_owned_after":35882.0,"shares_owned_after_display":"35,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-24","scope":"insider"},{"id":8389287,"accession":"0000914475-23-000082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-23-000082","line_url":"/filing/0000914475-23-000082#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20830.0,"shares_display":"20,830","price_per_share":119.8583,"price_display":"119.86","price_state":"stated","total_value":2496648.389,"total_display":"2,496,648.39","total_whole":"2,496,648","shares_owned_after":35882.0,"shares_owned_after_display":"35,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-08","scope":"insider"},{"id":8585463,"accession":"0001209191-23-056907","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056907","line_url":"/filing/0001209191-23-056907#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10919.0,"shares_display":"10,919","price_per_share":112.2732,"price_display":"112.27","price_state":"stated","total_value":1225911.0708,"total_display":"1,225,911.07","total_whole":"1,225,911","shares_owned_after":35882.0,"shares_owned_after_display":"35,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-29","scope":"insider"},{"id":8334625,"accession":"0001209191-23-047138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047138","line_url":"/filing/0001209191-23-047138#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2132.0,"shares_display":"2,132","price_per_share":107.388,"price_display":"107.39","price_state":"stated","total_value":228951.216,"total_display":"228,951.22","total_whole":"228,951","shares_owned_after":46991.0,"shares_owned_after_display":"46,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":8573507,"accession":"0001209191-23-007913","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-007913","line_url":"/filing/0001209191-23-007913#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":911.0,"shares_display":"911","price_per_share":104.0779,"price_display":"104.08","price_state":"stated","total_value":94814.9669,"total_display":"94,814.97","total_whole":"94,815","shares_owned_after":44973.0,"shares_owned_after_display":"44,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-08","scope":"insider"},{"id":8573503,"accession":"0001209191-23-007913","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-007913","line_url":"/filing/0001209191-23-007913","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14323.0,"shares_display":"14,323","price_per_share":102.40035526775117,"price_display":"102.40","price_state":"stated","total_value":1466680.2885,"total_display":"1,466,680.29","total_whole":"1,466,680","shares_owned_after":44157.0,"shares_owned_after_display":"44,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-07","filed_date":"2023-02-08","scope":"insider","n_lines":2},{"id":8573496,"accession":"0001209191-23-007913","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007913","line_url":"/filing/0001209191-23-007913#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1041.0,"shares_display":"1,041","price_per_share":105.8035,"price_display":"105.80","price_state":"stated","total_value":110141.4435,"total_display":"110,141.44","total_whole":"110,141","shares_owned_after":31290.0,"shares_owned_after_display":"31,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":8248083,"accession":"0001209191-23-006277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-006277","line_url":"/filing/0001209191-23-006277#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":109.9712,"price_display":"109.97","price_state":"stated","total_value":137464.0,"total_display":"137,464.00","total_whole":"137,464","shares_owned_after":30357.0,"shares_owned_after_display":"30,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":6854267,"accession":"0001209191-22-056436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-056436","line_url":"/filing/0001209191-22-056436#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5082.0,"shares_display":"5,082","price_per_share":125.0377,"price_display":"125.04","price_state":"stated","total_value":635441.5914,"total_display":"635,441.59","total_whole":"635,442","shares_owned_after":29234.0,"shares_owned_after_display":"29,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-08","filed_date":"2022-11-10","scope":"insider"},{"id":6127164,"accession":"0001209191-22-055837","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-055837","line_url":"/filing/0001209191-22-055837#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4518.0,"shares_display":"4,518","price_per_share":125.0224,"price_display":"125.02","price_state":"stated","total_value":564851.2032,"total_display":"564,851.20","total_whole":"564,851","shares_owned_after":29234.0,"shares_owned_after_display":"29,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-04","scope":"insider"},{"id":6374751,"accession":"0001209191-22-055391","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-055391","line_url":"/filing/0001209191-22-055391#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":125.0,"price_display":"125.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":29234.0,"shares_owned_after_display":"29,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-02","scope":"insider"},{"id":6374747,"accession":"0001209191-22-055391","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-055391","line_url":"/filing/0001209191-22-055391#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":120.0899,"price_display":"120.09","price_state":"stated","total_value":1200899.0,"total_display":"1,200,899.00","total_whole":"1,200,899","shares_owned_after":29234.0,"shares_owned_after_display":"29,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-02","scope":"insider"},{"id":6926778,"accession":"0001209191-22-054840","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-054840","line_url":"/filing/0001209191-22-054840#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4923.0,"shares_display":"4,923","price_per_share":115.0379,"price_display":"115.04","price_state":"stated","total_value":566331.5817,"total_display":"566,331.58","total_whole":"566,332","shares_owned_after":29234.0,"shares_owned_after_display":"29,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-27","filed_date":"2022-10-28","scope":"insider"},{"id":6926773,"accession":"0001209191-22-054840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-054840","line_url":"/filing/0001209191-22-054840#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5077.0,"shares_display":"5,077","price_per_share":115.0218,"price_display":"115.02","price_state":"stated","total_value":583965.6786,"total_display":"583,965.68","total_whole":"583,966","shares_owned_after":29234.0,"shares_owned_after_display":"29,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-28","scope":"insider"},{"id":6548527,"accession":"0001209191-22-052885","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-052885","line_url":"/filing/0001209191-22-052885#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":111.0446,"price_display":"111.04","price_state":"stated","total_value":1110446.0,"total_display":"1,110,446.00","total_whole":"1,110,446","shares_owned_after":29234.0,"shares_owned_after_display":"29,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6543084,"accession":"0001209191-22-020615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-020615","line_url":"/filing/0001209191-22-020615#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8455.0,"shares_display":"8,455","price_per_share":95.051,"price_display":"95.05","price_state":"stated","total_value":803656.205,"total_display":"803,656.20","total_whole":"803,656","shares_owned_after":29396.0,"shares_owned_after_display":"29,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-22","filed_date":"2022-03-22","scope":"insider"},{"id":6543080,"accession":"0001209191-22-020615","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-020615","line_url":"/filing/0001209191-22-020615#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":95.0,"price_display":"95.00","price_state":"stated","total_value":28500.0,"total_display":"28,500.00","total_whole":"28,500","shares_owned_after":37851.0,"shares_owned_after_display":"37,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-22","scope":"insider"},{"id":6565090,"accession":"0001209191-22-008213","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-008213","line_url":"/filing/0001209191-22-008213#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":911.0,"shares_display":"911","price_per_share":79.511,"price_display":"79.51","price_state":"stated","total_value":72434.521,"total_display":"72,434.52","total_whole":"72,435","shares_owned_after":38112.0,"shares_owned_after_display":"38,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-09","scope":"insider"},{"id":6565087,"accession":"0001209191-22-008213","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-008213","line_url":"/filing/0001209191-22-008213","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3168.0,"shares_display":"3,168","price_per_share":80.72136761363636,"price_display":"80.72","price_state":"stated","total_value":255725.2926,"total_display":"255,725.29","total_whole":"255,725","shares_owned_after":36363.0,"shares_owned_after_display":"36,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider","n_lines":3},{"id":5393836,"accession":"0001209191-21-009115","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-21-009115","line_url":"/filing/0001209191-21-009115","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36194.0,"shares_display":"36,194","price_per_share":116.17479529203736,"price_display":"116.17","price_state":"stated","total_value":4204830.5408,"total_display":"4,204,830.54","total_whole":"4,204,831","shares_owned_after":34361.0,"shares_owned_after_display":"34,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider","n_lines":3},{"id":5393820,"accession":"0001209191-21-009115","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009115","line_url":"/filing/0001209191-21-009115","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3407.0,"shares_display":"3,407","price_per_share":116.72270020545935,"price_display":"116.72","price_state":"stated","total_value":397674.2396,"total_display":"397,674.24","total_whole":"397,674","shares_owned_after":34361.0,"shares_owned_after_display":"34,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider","n_lines":3},{"id":5393811,"accession":"0001209191-21-009115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-009115","line_url":"/filing/0001209191-21-009115#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":605.0,"shares_display":"605","price_per_share":114.0539,"price_display":"114.05","price_state":"stated","total_value":69002.6095,"total_display":"69,002.61","total_whole":"69,003","shares_owned_after":30627.0,"shares_owned_after_display":"30,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"},{"id":2295137,"accession":"0001209191-20-058549","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058549","line_url":"/filing/0001209191-20-058549#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":90.7198,"price_display":"90.72","price_state":"stated","total_value":204754.5886,"total_display":"204,754.59","total_whole":"204,755","shares_owned_after":30082.0,"shares_owned_after_display":"30,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-16","scope":"insider"},{"id":3167369,"accession":"0001209191-20-045763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-045763","line_url":"/filing/0001209191-20-045763#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":118.8734,"price_display":"118.87","price_state":"stated","total_value":268297.2638,"total_display":"268,297.26","total_whole":"268,297","shares_owned_after":28051.0,"shares_owned_after_display":"28,051","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":3258458,"accession":"0001209191-20-042167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-042167","line_url":"/filing/0001209191-20-042167#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1657.0,"shares_display":"1,657","price_per_share":136.0204,"price_display":"136.02","price_state":"stated","total_value":225385.8028,"total_display":"225,385.80","total_whole":"225,386","shares_owned_after":26021.0,"shares_owned_after_display":"26,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-09","filed_date":"2020-07-10","scope":"insider"},{"id":2900058,"accession":"0001209191-20-038890","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038890","line_url":"/filing/0001209191-20-038890#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":130.0,"price_display":"130.00","price_state":"stated","total_value":650000.0,"total_display":"650,000.00","total_whole":"650,000","shares_owned_after":26021.0,"shares_owned_after_display":"26,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-25","scope":"insider"},{"id":2831952,"accession":"0001209191-20-031033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-031033","line_url":"/filing/0001209191-20-031033#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":120.0,"price_display":"120.00","price_state":"stated","total_value":600000.0,"total_display":"600,000.00","total_whole":"600,000","shares_owned_after":26021.0,"shares_owned_after_display":"26,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":2584846,"accession":"0001209191-20-026070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-026070","line_url":"/filing/0001209191-20-026070#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001504783","owner_name":"Lippoldt Darin","owner_display_name":"Lippoldt Darin","owner_url":"/insider/0001504783","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1934.0,"shares_display":"1,934","price_per_share":99.4912,"price_display":"99.49","price_state":"stated","total_value":192415.9808,"total_display":"192,415.98","total_whole":"192,416","shares_owned_after":26021.0,"shares_owned_after_display":"26,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-24","filed_date":"2020-04-28","scope":"insider"}],"collapsed":true,"next_cursor":"2020-04-24|2584846","ledger_fault":false,"count":{"value":91,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":91,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":91},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000914475","name":"NEUROCRINE BIOSCIENCES INC","url":"/issuer/0000914475","role":"Officer (Chief Legal Officer)","n_filings":52,"first_seen":"2015-11-10","last_seen":"2026-07-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001354217","name":"Volcano Corp","url":"/issuer/0001354217","role":"Officer (EVP, General Counsel)","n_filings":11,"first_seen":"2012-02-17","last_seen":"2014-03-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001504783","retrieved_at":"2026-08-24T07:13:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}